Orchestra BioMed
150 Union Square Drive
New Hope
PA
18938
917.254.4900
[email protected]
https://www.orchestrabiomed.com/
Product Categories
Balloon Catheter, Cath Lab, Drug-Eluting Balloons

Related Content

Orchestra BioMed and Medtronic, Inc., have an exclusive strategic collaboration for development and commercialization of AVIM therapy for hypertensive pacemaker population, which is estimated to be more than 750,000 patients annually worldwide
News | Hypertension
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk ...

Home January 19, 2024
arrow
Virtue Sirolimus-Eluting Balloon Earns FDA Breakthrough Device Designation
News | Drug-Eluting Balloons
Virtue Sirolimus-Eluting Balloon Earns FDA Breakthrough Device Designation

September 20, 2019 — Orchestra BioMed Inc., in partnership with Terumo Corp. announced the company has secured ...

Home September 20, 2019
arrow
Orchestra BioMed Partnering With Terumo Corp. for Development, Commercialization of Virtue Sirolimus-eluting Balloon
News | Drug-Eluting Balloons
Orchestra BioMed Partnering With Terumo Corp. for Development, Commercialization of Virtue Sirolimus-eluting Balloon

June 13, 2019 — Orchestra BioMed Inc. announced it has formed a global strategic partnership with Terumo Corp. for ...

Home June 13, 2019
arrow
BackBeat Cardiac Neuromodulation Therapy Shows Immediate, Substantial Blood Pressure Reduction
News | Hypertension
BackBeat Cardiac Neuromodulation Therapy Shows Immediate, Substantial Blood Pressure Reduction

June 4, 2019 — Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato I ...

Home June 04, 2019
arrow
Orchestra BioMed Receives FDA Breakthrough Device Designation for Virtue Sirolimus-eluting Balloon
Technology | Drug-Eluting Balloons
Orchestra BioMed Receives FDA Breakthrough Device Designation for Virtue Sirolimus-eluting Balloon

April 24, 2019 — Orchestra BioMed Inc. has secured Breakthrough Device designation by the U.S. Food and Drug ...

Home April 24, 2019
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now